ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(4), P. 3225 - 3258
Published: Feb. 6, 2023
The
immune
checkpoint
blockade
(ICB)
therapy
has
revolutionized
the
field
of
cancer
treatment,
while
low
response
rates
and
systemic
toxicity
limit
its
clinical
outcomes.
With
rapid
advances
in
nanotechnology
materials
science,
various
types
biomaterials
have
been
developed
to
maximize
therapeutic
efficacy
minimizing
side
effects
by
increasing
tumor
antigenicity,
reversing
immunosuppressive
microenvironment,
amplifying
antitumor
response,
reducing
extratumoral
distribution
inhibitors
as
well
enhancing
their
retention
within
target
sites.
In
this
review,
we
reviewed
current
design
strategies
for
different
augment
ICB
effectively
then
discussed
present
representative
biomaterial-assisted
modulation
targeted
delivery
boost
therapy.
Current
challenges
future
development
prospects
expanding
with
were
also
summarized.
We
anticipate
review
will
be
helpful
developing
emerging
promoting
application
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
34(15)
Published: Feb. 8, 2022
Sonodynamic
therapy
(SDT)
exhibits
high
tissue
penetration
and
negligible
radiation
damage
to
normal
tissues,
thus
emerges
as
a
promising
cancer
therapeutic
modality
for
glioblastoma
(GBM).
However,
the
blood-brain
barrier
(BBB)
hypoxic
microenvironment
greatly
limit
SDT
efficiency.
In
this
work,
biodegradable
nanoplatform
(termed
CSI)
is
fabricated
by
encapsulating
catalase
(CAT)
into
silica
nanoparticles
(CAT@SiO2
)
tumor
hypoxia
relief,
then
loaded
with
sonosensitizer
indocyanine
green
(ICG).
Inspired
ability
of
macrophages
cross
BBB,
CSI
further
coated
AS1411
aptamer-modified
macrophage
exosomes
form
CSI@Ex-A,
which
possesses
efficient
BBB
good
cancer-cell-targeting
capability.
After
cell
endocytosis,
highly
expressed
glutathione
(GSH)
triggeres
biodegradation
released
CAT
catalyzes
hydrogen
peroxide
(H2
O2
produce
relieve
hypoxia.
The
GSH
depletion
self-supplying
effectively
enhances
efficiency
both
in
vitro
vivo.
addition,
resulting
CSI@Ex-A
biocompatibility
long
circulation
time.
These
findings
demonstrate
that
may
serve
competent
GBM
therapy,
potential
clinical
translation.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(8), P. 12567 - 12603
Published: Aug. 2, 2021
Immunotherapy
that
harnesses
the
human
immune
system
to
fight
cancer
has
received
widespread
attention
and
become
a
mainstream
strategy
for
treatment.
Cancer
immunotherapy
not
only
eliminates
primary
tumors
but
also
treats
metastasis
recurrence,
representing
major
advantage
over
traditional
treatments.
Recently
with
development
of
nanotechnology,
there
exists
much
work
applying
nanomaterials
on
basis
their
excellent
physiochemical
properties,
such
as
efficient
tissue-specific
delivery
function,
huge
specific
surface
area,
controllable
chemistry.
Consequently,
nanotechnology
holds
significant
potential
in
improving
efficacy
immunotherapy.
Nanotechnology-based
mainly
manifests
its
inhibitory
effect
via
two
different
approaches:
one
is
produce
an
effective
anti-tumor
response
during
tumorigenesis,
other
enhance
tumor
defense
ability
by
modulating
suppression
mechanism
microenvironment.
With
success
immunotherapy,
understanding
interaction
between
smart
nanomedicine
provided
vigorous
vitality
This
review
highlights
application,
progress,
prospect
process
immunoediting
discusses
several
engineering
methods
improve
efficiency
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
34(51)
Published: Oct. 17, 2022
Immunogenic
cell
death
(ICD)
has
aroused
widespread
attention
because
it
can
reconstruct
a
tumor
microenvironment
and
activate
antitumor
immunity.
This
study
proposes
two-way
enhancement
of
ICD
based
on
CaO2
@CuS-MnO2
@HA
(CCMH)
nanocomposite
to
overcome
the
insufficient
damage-associated
molecular
patterns
(DAMPs)
conventional
ICD-inducers.
The
near-infrared
(NIR)
irradiation
(1064
nm)
CuS
nanoparticles
generates
1
O2
through
photodynamic
therapy
(PDT)
trigger
ICD,
also
damages
Ca2+
buffer
function
mitochondria.
Additionally,
react
with
H2
O
produce
large
amount
,
which
respectively
lead
enhanced
PDT
overload
during
mitochondrial
damage,
thereby
triggering
robust
activation.
Moreover,
oxidative-damaged
DNA,
induced
by
released
from
cells,
reprograms
immunosuppressive
transforming
tumor-associated
macrophages
M1
subphenotype.
shows
that
CCMH
NIR-II
elicit
adequate
DAMPs
an
active
tumor-immune
for
both
4T1
CT26
models.
Combining
this
method
immune
checkpoint
blockade
realize
improved
immunotherapy
efficacy
long-term
protection
effect
body.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
10(2)
Published: Nov. 27, 2022
Cancer
immunotherapy
effect
can
be
greatly
enhanced
by
other
methods
to
induce
immunogenic
cell
death
(ICD),
which
has
profoundly
affected
as
a
highly
efficient
paradigm.
However,
these
treatments
have
significant
limitations,
either
causing
damage
of
the
immune
system
or
limited
superficial
tumors.
Sonodynamic
therapy
(SDT)
ICD
promote
without
affecting
because
its
excellent
spatiotemporal
selectivity
and
low
side
effects.
Nevertheless,
SDT
is
still
reactive
oxygen
species
yield
complex
tumor
microenvironment.
Recently,
some
emerging
SDT-based
nanomedicines
made
numerous
attractive
encouraging
achievements
in
field
cancer
due
high
immunotherapeutic
efficiency.
this
cross-cutting
research
far
from
being
widely
explored
huge
professional
barriers.
Herein,
characteristics
microenvironment
mechanisms
are
firstly
systematically
summarized.
Subsequently,
therapeutic
mechanism
fully
summarized,
advantages
limitations
discussed.
The
representative
advances
for
further
highlighted.
Finally,
application
prospects
challenges
future
clinical
translation
Chemical Reviews,
Journal Year:
2024,
Volume and Issue:
124(5), P. 2699 - 2804
Published: Feb. 29, 2024
The
ability
to
gain
spatiotemporal
information,
and
in
some
cases
achieve
control,
the
context
of
drug
delivery
makes
theranostic
fluorescent
probes
an
attractive
intensely
investigated
research
topic.
This
interest
is
reflected
steep
rise
publications
on
topic
that
have
appeared
over
past
decade.
Theranostic
probes,
their
various
incarnations,
generally
comprise
a
fluorophore
linked
masked
drug,
which
released
as
result
certain
stimuli,
with
both
intrinsic
extrinsic
stimuli
being
reported.
release
then
signaled
by
emergence
signal.
Importantly,
use
appropriate
fluorophores
has
enabled
not
only
this
emerging
fluorescence
marker
for
but
also
provided
modalities
useful
photodynamic,
photothermal,
sonodynamic
therapeutic
applications.
In
review
we
highlight
recent
work
particular
focus
are
activated
tumor
microenvironments.
We
summarize
efforts
develop
other
applications,
such
neurodegenerative
diseases
antibacterials.
celebrates
diversity
designs
reported
date,
from
discrete
small-molecule
systems
nanomaterials.
Our
aim
provide
insights
into
potential
clinical
impact
still-emerging
direction.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
16(1), P. 485 - 501
Published: Dec. 28, 2021
The
tumor
microenvironment
(TME)
featured
by
immunosuppression
and
hypoxia
is
pivotal
to
cancer
deterioration
metastasis.
Thus,
regulating
the
TME
improve
cell
ablation
efficiency
has
received
extensive
interest
in
oncotherapy.
However,
reverse
alleviate
simultaneously
are
major
challenges
for
effective
therapy.
Herein,
a
multifunctional
platform
based
on
Au
nanoparticles
carbon
dots
modified
hollow
black
TiO2
nanosphere
(HABT-C)
with
intrinsic
cascade
enzyme
mimetic
activities
prepared
reversing
alleviating
TME.
HABT-C
NPs
possess
triple-enzyme
activity
act
as
self-cascade
nanozymes,
which
produce
sufficient
oxygen
generate
abundant
ROS.
theoretical
analysis
demonstrates
that
facilitates
absorption
of
H2O
O2,
separation
electron–holes,
generation
ROS,
consequently
amplifying
sonodynamic
therapy
(SDT)
efficiency.
Specifically,
exhibits
favorable
inhibition
immunosuppressive
mediator
expression,
along
infiltrating
immune
effector
cells
into
As
result,
can
effectively
kill
via
eliciting
infiltration,
hypoxia,
improving
SDT
This
nanozyme-based
(HABT-C@HA)
will
provide
strategy
highly
efficient
against
modulation
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(33)
Published: March 7, 2023
Abstract
Immunotherapy
has
made
remarkable
strides
in
cancer
therapy
over
the
past
decade.
However,
such
emerging
still
suffers
from
low
response
rates
and
immune‐related
adverse
events.
Various
strategies
have
been
developed
to
overcome
these
serious
challenges.
Therein,
sonodynamic
(SDT),
as
a
non‐invasive
treatment,
received
ever‐increasing
attention
especially
treatment
of
deep‐seated
tumors.
Significantly,
SDT
can
effectively
induce
immunogenic
cell
death
trigger
systemic
anti‐tumor
immune
response,
termed
immunotherapy.
The
rapid
development
nanotechnology
revolutionized
effects
with
robust
induction.
As
result,
more
innovative
nanosonosensitizers
synergistic
modalities
are
established
superior
efficacy
safe
profile.
In
this
review,
recent
advances
immunotherapy
summarized
particular
emphasis
on
how
be
explored
harness
for
amplifying
response.
Moreover,
current
challenges
field
prospects
its
clinical
translation
also
presented.
It
is
anticipated
that
review
provide
rational
guidance
facilitate
nanomaterials‐assisted
immunotherapy,
helping
pave
way
next‐generation
eventually
achieve
durable
patients.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(10), P. 16934 - 16945
Published: Oct. 18, 2021
Nanomedicine
has
revolutionized
cancer
therapeutic
strategies
but
not
completely
changed
the
outcomes
of
tricky
tumors
that
evolve
a
sophisticated
immunosuppressive
tumor
microenvironment
(TME)
such
as
acidification.
Here,
metal-phenolic
network-based
nanocomplex
embedded
with
lactate
oxidase
(LOX)
and
mitochondrial
respiration
inhibitor
atovaquone
(ATO)
was
constructed
for
TME
remodeling
sonodynamic
therapy
(SDT).
In
this
nanocomplex,
sonosensitizer
chlorin
e6-conjugated
polyphenol
derivative
can
induce
generation
lethal
reactive
oxygen
species
upon
ultrasound
irradiation.
LOX
served
catalyst
intracellular
lactic
acid
exhaustion,
ATO
led
to
dysfunction
decrease
consumption.
This
reversed
status
by
alleviating
hypoxia
acidic
TME,
achieving
characteristic
enhancement
SDT
inhibition
proliferation
metastasis.
Nano Letters,
Journal Year:
2021,
Volume and Issue:
21(18), P. 7862 - 7869
Published: Sept. 8, 2021
Blocking
energy
metabolism
of
cancer
cells
and
simultaneously
stimulating
the
immune
system
to
perform
attack
are
significant
for
treatment.
However,
how
potently
deliver
different
drugs
with
these
functions
remains
a
challenge.
Herein,
we
synthesized
nanoprodrug
formed
by
F127-coated
drug
dimer
inhibit
glycolysis
alleviate
immunosuppressive
microenvironment.
The
was
delicately
constructed
connect
lonidamine
(LND)
NLG919
disulfide
bond
which
can
be
cleaved
excess
GSH
release
two
drugs.
LND
decrease
expression
hexokinase
II
destroy
mitochondria
restrain
supply.
reduce
accumulation
kynurenine
number
regulatory
T
cells,
thus
alleviating
Notably,
consumption
increased
intracellular
oxidative
stress
triggered
immunogenic
cell
death
cells.
This
strategy
offer
more
possibilities
explore
dimeric
prodrugs
synergistic
therapy.